About
FluidForm Bio develops a 3D bioprinting platform called FRESH to create implantable, vascularized tissues aimed at enabling minimally invasive treatments for diseases such as type 1 diabetes.
Explore FluidForm Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.